Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) Key Statistics
$7.20TWO: 4186.TWOMarket Cap $653.40M
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
40.33
P/B ratioShare price divided by book value per share.
2.43
P/S ratioMarket value divided by annual revenue.
1.87
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
19.42
EV / RevenueEnterprise value against annual revenue.
2.28
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
2.48%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
61.30%
Operating marginRevenue left after operating costs.
-7.95%
Net marginRevenue left after every cost, including tax and interest.
4.52%
Return on equityProfit as a percentage of shareholders’ equity.
6.05%
Return on assetsProfit as a percentage of total assets.
2.32%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.98
Quick ratioThe same, excluding inventory.
0.88
Debt to equityTotal borrowings against shareholders’ equity.
1.10
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.18
Book value per shareShareholders’ equity divided by shares outstanding.
$2.98
Shares outstandingShares currently issued.
90,000,000
Market capitalisationShare price times shares outstanding.
$653.40M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
160
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) statistics — frequently asked questions
What is Taiwan Advance Bio-Pharmaceutical Inc.'s P/E ratio?
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) trades on a price-to-earnings ratio of 40.33.
What is Taiwan Advance Bio-Pharmaceutical Inc.'s return on equity?
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) reports a return on equity of 6.05%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Taiwan Advance Bio-Pharmaceutical Inc. carry?
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) has a debt-to-equity ratio of 1.10, which compares total borrowings with shareholders' equity.
What is Taiwan Advance Bio-Pharmaceutical Inc.'s profit margin?
Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO) keeps 4.52% of revenue as net profit after every cost, including tax and interest.